XB
Xanadu Bio, Inc.
SEC filingBiotechnology · Gladwyne, PA
Amount raised$11Msold at filing
Total offering$11M
Investors in the raise4count reported to the SEC
FiledAug 27, 2025first sale Aug 13, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Taylor FeehleyExecutive Officer
Mark SaltzmanDirector
Todd WiderDirector, Executive Officer, Promoter
Bruce TurnerDirector, Executive Officer, Promoter
Executive officers, directors and promoters as listed on the Form D.